Posted by Teri Schroder on Aug 29th, 2016
After a huge backlash against Mylan (NASDAQ:MYL) over hiking the price of the lifesaving EpiPen, the company has announced that it will soon be releasing a cheaper generic version of the device. The EpiPen provides a rapid injection...
More of this article »